Cellectar Biosciences, Inc. (CLRB)
NCM · Common · CUSIP 15117F500
Last Price•••.••
Current Yield•.••%
Yield to Call•.••%
Yield to Worst•.••%
Free registration unlocks the quote, yield calculations, price chart and full fundamentals for CLRB and every other security on QuantumOnline.
🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD. Register free to view.

Security Profile

Security Type
Common Stock
CUSIP
15117F500 (prev. 15117F302 )
Market Cap
Micro Cap
IPO
8/13/2014 · $3.75/share
Previous Symbol
NVLT (changed 2/11/2014)
Previous Name
Novelos Therapeutics, Inc.
Business: Cellectar Biosciences, Inc. is a clinical stage biopharmaceutical company developing innovative agents for the detection and treatment of cancer.
Notes: March 7, 2016 -- Cellectar Biosciences, Inc. (CLRB & CLRBW) will effect a one-for-ten (1-10) reverse split of its common stock and warrants. The CUSIP number will change to 15117F302 & 15117F120 respectively.

Company Contact

CEO
James Caaruso
CFO
Chad Kolean
Headquarters
100 Campus Drive Florham Park, NJ 07932
Phone
608-441-8120
Fax
608-441-8121
Investor Relations
Monique Kosse, LifeSci Advisors · 212-915-3820 · monique@lifesciadvisors.com
General Email
investors@cellectar.com
Email Form
Contact Form »
SEC EDGAR Filings
View filings »